| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |